Triclabendazole 50 mg, albendazole 37.5 mg, excipients q.s.ad. 1 mL
Tri-ABZ® 8.75
Oral Suspension
Full-spectrum antiparasitic
Formulation
Indications
For the simultaneous treatment and control of all internal parasitosis: gastrointestinal and pulmonary nematodes, taenias and Fasciola hepatica (early immature, immature and adult stages).
Dosage and Administration
1 mL/5 kg of b.w. Administer through oral route.
Commercial Presentation
Bottle x 1 L ,
SENASA Registry
SENASA Perú: F.07.02.N.0274
MORE VISITED PRODUCTS
Vetonic® con Nucleótidos OS
Oral SolutionIntegral biostimulant, growth promoter. Unique with nucleotides
